What is the appropriate weight-based dose of carbimazole (generic name) for treating hyperthyroidism in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Carbimazole Weight-Based Dosing

For children with hyperthyroidism, carbimazole should be initiated at 0.4-0.8 mg/kg/day (maximum 30 mg/day), with the dose adjusted based on disease severity. 1

Pediatric Dosing

The most recent guidelines from 2018 provide clear weight-based recommendations for children:

  • Initial dose: 0.4-0.8 mg/kg/day (up to maximum 30 mg daily) 1
  • Moderate hyperthyroidism: Start at 0.4 mg/kg/day
  • Severe hyperthyroidism: Use doses 50-100% higher (up to 0.8 mg/kg/day)

Age-Specific Considerations

Children under 7 years require higher weight-based doses and take longer to achieve euthyroidism compared to older children. Research demonstrates that children <7 years need a mean dose of 0.71 mg/kg/day versus 0.44-0.50 mg/kg/day in older children 2. These younger patients also require 6.2 months on average to normalize free T4 compared to 3.1-3.2 months in older children.

Maintenance Dosing in Children

Once euthyroidism is achieved, reduce the dose by 30-50% to a maintenance level of 5-15 mg/day 1. The dose should be titrated to maintain the minimum effective level.

Adult Dosing

For adults, carbimazole dosing is based on disease severity rather than strict weight-based calculations:

  • Initial dose: 10-20 mg daily (equivalent to methimazole 10-20 mg, since 10 mg carbimazole converts to approximately 6 mg methimazole) 3
  • Maintenance dose: 5-10 mg daily after achieving euthyroidism 3

Severity-Based Approach in Adults

  • Mild-moderate hyperthyroidism: 10-20 mg daily initially 4
  • Severe hyperthyroidism (T4 >260 nmol/L): Higher doses (up to 40 mg daily) may be required 4

Administration Guidelines

Once-daily dosing is preferred for both adults and children to improve compliance 1, 5. Studies demonstrate that single daily dosing is equally effective as divided doses and results in better adherence (83% vs 53% compliance) 3.

Critical Monitoring Points

Before Initiating Therapy

  • Complete blood count with differential 3, 1
  • Liver function tests (transaminases, bilirubin, alkaline phosphatase) 3, 1

During Treatment

  • Monitor free T4, free T3, and TSH after 2 weeks, then monthly until TSH normalizes 1
  • Once stable, quarterly monitoring of TSH is sufficient 1

Important Caveats

Avoid "block and replace" regimens (high-dose carbimazole plus levothyroxine), as meta-analyses show increased adverse events without clinical benefit 3, 1.

Propylthiouracil is contraindicated in children due to unacceptable hepatotoxicity risk (1 in 2000-4000 children) 3, 1.

Safety Warnings

Patients must immediately stop medication and contact their physician if they develop:

  • Fever, pharyngitis, or mouth sores (agranulocytosis risk)
  • Jaundice, dark urine, or abdominal pain (hepatotoxicity)
  • Pruritic rash or arthralgias 3, 1

First trimester pregnancy: Switch to propylthiouracil due to carbimazole embryopathy risk (choanal atresia, esophageal atresia, aplasia cutis) 3, 6.

Treatment Duration

Children typically require 3-6 years of therapy before attempting discontinuation, significantly longer than adults 1. Only 50% of pediatric patients achieve remission with medical therapy alone 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.